Risk for Cancer in Parents of Patients With Schizophrenia
about
Tobacco use among individuals with schizophrenia: what role has the tobacco industry played?Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability.Cancer and schizophrenia: is there a paradox?The risk of schizophrenia and child psychiatric disorders in offspring of mothers with lung cancer and other types of cancer: a Danish nationwide register studyProstate cancer and neuroendocrine differentiation: more neuronal, less endocrine?Schizophrenia, cancer and obstetric complications in an evolutionary perspective-an empirically based hypothesisImproving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden.Schizophrenia and cancer: in 2010 do we understand the connection?The evolutionary paradox and the missing heritability of schizophrenia.Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders.Evidence of aberrant DNA damage response signalling but normal rates of DNA repair in dividing lymphoblasts from patients with schizophrenia.Reduced cancer incidence among patients with schizophrenia.Cancer incidence in patients with schizophrenia and their first-degree relatives - a meta-analysis.Identification of shared genetic variants between schizophrenia and lung cancer.Familial and sporadic schizophrenia: a comparison of somatic diseases and abuse in patients and their relatives.The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancerSchizophrenia: The Epidemiological Horizon
P2860
Q24643892-3DE1CFFC-9AC7-4EE7-A4B2-0E7D828B9C02Q33766947-E2D3F842-3E99-4E6D-B624-D4AB47F065E4Q34183508-08A398DD-5090-49E0-B71D-2A40D02AF006Q35041116-2F11215D-58B8-4B08-8897-832026473717Q35141115-0254FB94-18FC-4F33-88BA-EE557F46A0EDQ35144224-07A6B2D1-1C9E-480F-91A2-895EB6B6F52DQ36267882-7E18FDE3-23B6-4618-A7D3-B47CEF6D02B4Q36770024-B792B3F9-5A5B-48B9-987A-A5CAB1224F19Q37822484-2470D6FB-4409-4A3C-8812-E0F4F19AB0BEQ38077155-2BE1B33F-8528-48B1-9455-6D4200AC28ADQ38091301-4B32BECA-A041-4C3B-9AEB-0605F9DB38FAQ39492329-0C5558BF-4401-4BE5-B9D2-07A91030FE4DQ44255437-EF887624-8713-4AE3-B222-BEC8B041683CQ44786818-F4F92F0E-9CBA-42EA-A9FA-3096B6C0C056Q47556321-29793914-844C-4AEC-A321-ED66523412C3Q51872799-064E635D-721D-4855-AD4A-3AB37B66065FQ58579097-6C62D983-974A-4D83-B2F1-6D370A034E3CQ59117302-93F69D32-2339-48F8-A14E-8237D320B4EB
P2860
Risk for Cancer in Parents of Patients With Schizophrenia
description
im Mai 2004 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2004
@uk
name
Risk for Cancer in Parents of Patients With Schizophrenia
@en
Risk for Cancer in Parents of Patients With Schizophrenia
@nl
type
label
Risk for Cancer in Parents of Patients With Schizophrenia
@en
Risk for Cancer in Parents of Patients With Schizophrenia
@nl
prefLabel
Risk for Cancer in Parents of Patients With Schizophrenia
@en
Risk for Cancer in Parents of Patients With Schizophrenia
@nl
P50
P1476
Risk for Cancer in Parents of Patients With Schizophrenia
@en
P2093
Lene Mellemkjær
P304
P356
10.1176/APPI.AJP.161.5.903
P407
P577
2004-05-01T00:00:00Z